Evidence map›Paper›PMID 42444449›Full record

ArticleeLife2026

A natural experiment in Kenya reveals durable immunosuppressive effects of early childhood malaria: a longitudinal cohort study.

Mercy S Safari, Timothy O Makori, Elijah T Gicheru, Maureen W Mburu, Omar K Nyawa, Faiz M Shee, James Nyagwange, Eunice W Kagucia, Francis Maina Ndungu, Timothy Chege Kuria and 2 more

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mercy S SafariBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID https://orcid.org/0009-0007-7610-8252
Timothy O MakoriBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Elijah T GicheruBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Maureen W MburuBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Omar K NyawaBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Faiz M SheePwani University, Kilifi, Kenya.
James NyagwangeBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Eunice W KaguciaBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Francis Maina NdunguBioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID https://orcid.org/0000-0002-8977-0030
Timothy Chege KuriaDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, United States.
James O Tuju *Bioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Charles J Sande *Bioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.ORCID https://orcid.org/0000-0002-8364-6063

Funding

Wellcome 10.35802/105882Wellcome Trust
6 · The paper itself

Abstract

Background: Chronic malaria exposure has been proposed to modulate immune function, but its long-term effects on antibody-mediated responses to unrelated pathogens remain poorly defined. Whether these effects persist beyond periods of active infection and how early-life exposure shapes humoral immunity over time is not well understood. Methods: We leveraged a natural experiment in coastal Kenya - where two regions (Junju and Ngerenya) diverged sharply in malaria transmission from around 2004 - to evaluate the long-term immunological consequences of malaria exposure in childhood. Using a protein microarray platform, we measured IgG responses to vaccine and pathogen antigens in 123 children sampled longitudinally over a 15-year period. Active weekly malaria surveillance enabled precise reconstruction of individual exposure histories. Results: IgG responses to Conclusions: These findings suggest that malaria exposure during early childhood is linked with durable suppression of antibody responses to unrelated pathogens and vaccines. This effect persists long after infection and may partially explain the overall diminished long-term vaccine effectiveness in malaria-endemic settings. Funding: This study was supported by fellowship funding to C.J.S. from the Wellcome Trust (WT105882MA). The funder played no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript. M.S.S was funded in whole by Science for Africa Foundation to the Developing Excellence in Leadership, Training, and Science in Africa (DELTAS Africa) program [DEL-22-012] with support from Wellcome Trust and the UK Foreign, Commonwealth & Development Office and is part of the EDCPT2 programme supported by the European Union. For purposes of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.

Indexed as

Immune ToleranceMalaria, FalciparumPlasmodium falciparumAntibodies, ProtozoanAntigens, ProtozoanChildChild, PreschoolFemaleHumansImmunoglobulin GInfantKenyaLongitudinal StudiesMalaria VaccinesMaleMembrane ProteinsAntibodies, ProtozoanAntigens, Protozoanapical membrane antigen I, PlasmodiumImmunoglobulin GMalaria VaccinesMembrane ProteinsProtozoan Proteinsantibodyepidemiologyglobal healthimmunosupressionmalarianatural experimentP. falciparum

Identifiers

PMID42444449
PMCPMC13368175

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.